Skip to main content
Fig. 1 | Trials

Fig. 1

From: Oropharyngeal administration of mother’s colostrum, health outcomes of premature infants: study protocol for a randomized controlled trial

Fig. 1

Timeline of the study. After informed consent is obtained, the infant is enrolled, randomized, and begins receiving treatments. The treatments are given until the infant reaches 32 weeks CGA. Health outcome data is collected throughout the infant’s hospitalization until NICU discharge. CGA, corrected gestational age; NICU, neonatal intensive care unit

Back to article page

Trials

ISSN: 1745-6215